Literature DB >> 2686440

Candida albicans: cellular immune system interactions during different stages of the menstrual cycle.

A Kalo-Klein1, S S Witkin.   

Abstract

Candidal vaginitis most often recurs during pregnancy and in the late luteal phase just before menstruation. We examined the influence of the stage of the menstrual cycle on the cellular immune response to Candida albicans, the efficiency of C. albicans germination in sera, and the ability of products from activated lymphoid cells to inhibit germination. C. albicans germination was maximal in sera obtained during the luteal phase. During this period the cellular immune response to Candida was reduced as was the inhibition of Candida germination by products of activated peripheral blood mononuclear cells. Variations in immune response to Candida were of much lesser magnitude in women who took oral contraceptives, which suggests that it was the marked fluctuation in progesterone or estradiol levels during the menstrual cycle that influenced the changes in the immune response to C. albicans. Thus the hormonal status of women may influence the pathogenicity of C. albicans by modulation of immune system activity. These results explain the clinical observation that candidal vaginitis infections most frequently reappear before menstruation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686440     DOI: 10.1016/0002-9378(89)90649-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  A new model of vaginal infection by Candida albicans in rats.

Authors:  Márcia A Carrara; Lucélia Donatti; Edílson Damke; Terezinha I E Svidizinski; Márcia E L Consolaro; Márcia R Batista
Journal:  Mycopathologia       Date:  2010-06-09       Impact factor: 2.574

2.  Broad tissue expression of membrane progesterone receptor Alpha in normal mice.

Authors:  Shaojin You; Lian Zuo; Vijay Varma
Journal:  J Mol Histol       Date:  2010-05-15       Impact factor: 2.611

3.  Effects of reproductive hormones on experimental vaginal candidiasis.

Authors:  P L Fidel; J Cutright; C Steele
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.

Authors:  A C Roth; I Milsom; L Forssman; P Wåhlén
Journal:  Genitourin Med       Date:  1990-10

5.  A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells.

Authors:  Mary Mayumi Taguti Irie; Márcia Edilaine Lopes Consolaro; Terezinha Aparecida Guedes; Lucélia Donatti; Eliana Valéria Patussi; Terezinha Inez Estivalet Svidzinski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

6.  Cellular immunity in recurrent vulvovaginal candidiasis.

Authors:  E M Corrigan; R L Clancy; M L Dunkley; F M Eyers; K W Beagley
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 7.  Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions.

Authors:  Peter Thomas
Journal:  Front Neuroendocrinol       Date:  2008-02-01       Impact factor: 8.606

Review 8.  Evaluation and management of vaginitis.

Authors:  P L Carr; D Felsenstein; R H Friedman
Journal:  J Gen Intern Med       Date:  1998-05       Impact factor: 5.128

9.  Reward Responsiveness and Ruminative Styles Interact to Predict Inflammation and Mood Symptomatology.

Authors:  Daniel P Moriarity; Tommy Ng; Madison K Titone; Iris K-Y Chat; Robin Nusslock; Gregory E Miller; Lauren B Alloy
Journal:  Behav Ther       Date:  2019-11-26

Review 10.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.